(Q39663614)

13 September 2017

title

Glucosamine exerts a neuroprotective effect via suppression of inflammation in rat brain ischemia/reperfusion injury (English)

1 reference

13 September 2017

0 references

1 reference

0 references

So-Young Hwang

1

1 reference

13 September 2017

Joo-Hyun Shin

2

1 reference

13 September 2017

Ji-Sun Hwang

3

1 reference

13 September 2017

Song-Yi Kim

4

1 reference

13 September 2017

Jin-A Shin

5

1 reference

13 September 2017

Eok-Soo Oh

6

1 reference

13 September 2017

Seikwan Oh

7

1 reference

13 September 2017

Jung-Bin Kim

8

1 reference

13 September 2017

Ja-Kyung Lee

9

1 reference

13 September 2017

Inn-Oc Han

10

1 reference

13 September 2017

language of work or name

English

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20737476

22 June 2024

publication date

1 November 2010

1 reference

13 September 2017

15 November 2010

1 reference

National Center for Biotechnology Information

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/esummary.fcgi?db=pubmed&retmode=json&id=20737476

full work available at URL

22 June 2024

https://api.wiley.com/onlinelibrary/tdm/v1/articles/10.1002%2Fglia.21058

1 reference

https://api.crossref.org/works/10.1002/GLIA.21058

https://onlinelibrary.wiley.com/doi/pdf/10.1002/glia.21058

22 June 2024

1 reference

https://api.crossref.org/works/10.1002/GLIA.21058

22 June 2024

1 reference

13 September 2017

volume

58

1 reference

13 September 2017

issue

15

1 reference

13 September 2017

page(s)

1881-1892

1 reference

Coexamination of site-specific transcription factor binding and promoter activity in living cells

13 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

Therapeutic benefit of intravenous administration of bone marrow stromal cells after cerebral ischemia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

Reduced O glycosylation of Sp1 is associated with increased proteasome susceptibility

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

TGF-beta1 represses activation and resultant death of microglia via inhibition of phosphatidylinositol 3-kinase activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

Nitric oxide, ischaemia and brain inflammation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

O glycosylation of an Sp1-derived peptide blocks known Sp1 protein interactions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

Glucosamine abrogates the acute phase of experimental autoimmune encephalomyelitis by induction of Th2 response

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

Localization of the O-GlcNAc transferase and O-GlcNAc-modified proteins in rat cerebellar cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Glucosamine induces insulin resistance in vivo by affecting GLUT 4 translocation in skeletal muscle. Implications for glucose toxicity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Stimulation of proteoglycan production by glucosamine sulfate in chondrocytes isolated from human osteoarthritic articular cartilage in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Hexosamines, insulin resistance, and the complications of diabetes: current status

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Quantitative analysis of binding of transcription factor complex to biotinylated DNA probe by a streptavidin–agarose pulldown assay

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Glucosamine modulates IL-1-induced activation of rat chondrocytes at a receptor level, and by inhibiting the NF-kappa B pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Cycling of O-linked beta-N-acetylglucosamine on nucleocytoplasmic proteins

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Role of the glucosamine pathway in fat-induced insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

A novel gene iba1 in the major histocompatibility complex class III region encoding an EF hand protein expressed in a monocytic lineage

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Flux through the hexosamine pathway is a determinant of nuclear factor kappaB- dependent promoter activation

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Dynamic interplay between O-glycosylation and O-phosphorylation of nucleocytoplasmic proteins: a new paradigm for metabolic control of signal transduction and transcription

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Activation of the hexosamine pathway leads to deterioration of pancreatic beta-cell function through the induction of oxidative stress

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Phosphorylation meets ubiquitination: the control of NF-[kappa]B activity

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Sodium butyrate suppresses interferon-gamma-, but not lipopolysaccharide-mediated induction of nitric oxide and tumor necrosis factor-alpha in microglia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

HMGB1, a novel cytokine-like mediator linking acute neuronal death and delayed neuroinflammation in the postischemic brain.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Selective ablation of proliferating microglial cells exacerbates ischemic injury in the brain.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Glucosamine inhibits IL-1beta-induced NFkappaB activation in human osteoarthritic chondrocytes

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Distinct localization of SAPK isoforms in neurons of adult mouse brain implies multiple signaling modes of SAPK pathway

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Does O-GlcNAc play a role in neurodegenerative diseases?

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Increased hexosamine biosynthesis and protein O-GlcNAc levels associated with myocardial protection against calcium paradox and ischemia

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Accumulation of protein O-GlcNAc modification inhibits proteasomes in the brain and coincides with neuronal apoptosis in brain areas with high O-GlcNAc metabolism

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Glucosamine: a review of its use in the management of osteoarthritis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

The neglect of glucosamine as a treatment for osteoarthritis--a personal perspective

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Glucosamine Inhibits Inducible Nitric Oxide Synthesis

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Antisense oligodeoxynucleotide to inducible nitric oxide synthase protects against transient focal cerebral ischemia-induced brain injury.

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Expression of GLUT-2 cDNA in human B lymphocytes: analysis of glucose transport using flow cytometry

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Diverse regulation of protein function by O-GlcNAc: a nuclear and cytoplasmic carbohydrate post-translational modification

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

O-GlcNAc turns twenty: functional implications for post-translational modification of nuclear and cytosolic proteins with a sugar

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

A role for N-acetylglucosamine as a nutrient sensor and mediator of insulin resistance

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Disrupting the enzyme complex regulating O-GlcNAcylation blocks signaling and development

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

O-linkage of N-acetylglucosamine to Sp1 activation domain inhibits its transcriptional capability

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Inhibitory effects of glucosamine on lipopolysaccharide-induced activation in microglial cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

Dynamic O-GlcNAc modification of nucleocytoplasmic proteins in response to stress. A survival response of mammalian cells

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

O-GlcNAc modification is an endogenous inhibitor of the proteasome

1 reference

https://api.crossref.org/works/10.1002%2FGLIA.21058

7 January 2021

The hexosamine signaling pathway: deciphering the "O-GlcNAc code"

https://api.crossref.org/works/10.1002/GLIA.21058

29

1 reference

22 June 2024

Identifiers

DOI

10.1002/GLIA.21058

1 reference

13 September 2017

1 reference